BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2949692)

  • 1. Correlates of early disability in Huntington's disease.
    Mayeux R; Stern Y; Herman A; Greenbaum L; Fahn S
    Ann Neurol; 1986 Dec; 20(6):727-31. PubMed ID: 2949692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional decline in Huntington's disease.
    Feigin A; Kieburtz K; Bordwell K; Como P; Steinberg K; Sotack J; Zimmerman C; Hickey C; Orme C; Shoulson I
    Mov Disord; 1995 Mar; 10(2):211-4. PubMed ID: 7753064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified Huntington's disease rating scale: a follow up.
    Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
    Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors contributing to institutionalization in patients with Huntington's disease.
    Rosenblatt A; Kumar BV; Margolis RL; Welsh CS; Ross CA
    Mov Disord; 2011 Aug; 26(9):1711-6. PubMed ID: 21538527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
    van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
    Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of adaptive functioning in Huntington's disease.
    Bylsma FW; Rothlind J; Hall MR; Folstein SE; Brandt J
    Mov Disord; 1993 Apr; 8(2):183-90. PubMed ID: 8474487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of neuropathological severity in 100 patients with Huntington's disease.
    Rosenblatt A; Abbott MH; Gourley LM; Troncoso JC; Margolis RL; Brandt J; Ross CA
    Ann Neurol; 2003 Oct; 54(4):488-93. PubMed ID: 14520661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is "subcortical dementia" a recognizable clinical entity?
    Mayeux R; Stern Y; Rosen J; Benson F
    Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
    Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
    Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
    Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visuospatial cognition in Huntington's disease.
    Mohr E; Brouwers P; Claus JJ; Mann UM; Fedio P; Chase TN
    Mov Disord; 1991; 6(2):127-32. PubMed ID: 1829137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex movement behaviour and progression of Huntington's disease.
    Andrich J; Saft C; Ostholt N; Müller T
    Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
    J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.
    Kingma EM; van Duijn E; Timman R; van der Mast RC; Roos RA
    Gen Hosp Psychiatry; 2008; 30(2):155-61. PubMed ID: 18291297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of locomotion disorders in Huntington's disease].
    Delval A; Krystkowiak P; Blatt JL; Delliaux M; Destée A; Derambure P; Defebvre L
    Neurophysiol Clin; 2008 Apr; 38(2):117-25. PubMed ID: 18423332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
    Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.
    Penney JB; Young AB; Shoulson I; Starosta-Rubenstein S; Snodgrass SR; Sanchez-Ramos J; Ramos-Arroyo M; Gomez F; Penchaszadeh G; Alvir J
    Mov Disord; 1990; 5(2):93-9. PubMed ID: 2139171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the striatum in rule application: the model of Huntington's disease at early stage.
    Teichmann M; Dupoux E; Kouider S; Brugières P; Boissé MF; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Brain; 2005 May; 128(Pt 5):1155-67. PubMed ID: 15788544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease.
    Finke K; Bublak P; Dose M; Müller HJ; Schneider WX
    Brain; 2006 May; 129(Pt 5):1137-51. PubMed ID: 16504973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.